Your browser doesn't support javascript.
loading
Quality corner: Safely using cephalosporins in almost all patients with penicillin allergies: Mini-review and suggested protocol to improve efficacy and surgical outcomes.
Boitano, Teresa K L; Virk, Abinash; Michael Straughn, J; Dowdy, Sean C.
Afiliação
  • Boitano TKL; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Virk A; Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, MN, USA.
  • Michael Straughn J; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Dowdy SC; Division of Gynecologic Oncology, Mayo Clinic, Rochester, MN, USA.
Gynecol Oncol Rep ; 53: 101389, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38623269
ABSTRACT
Surgical site infections (SSI) are one of the most common gynecologic oncology postoperative complications and they have a significant deleterious impact on the healthcare system and in patients' outcomes. Cefazolin is the recommended antibiotic in women undergoing gynecologic surgical procedures that require that require prophylaxis. However, 10-20% of patients may report a penicillin allergy which can result in administration of a less effective antibiotic. This quality review evaluated the literature around this common perioperative issue and demonstrated that healthcare teams should consider the implementation of a protocol to safely use cefazolin in most patients with a penicillin allergy. Overall, literature shows this is a safe adjustment and would improve antimicrobial stewardship, decrease SSI rates, avoid acute kidney injury, and increase cost savings.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article